110 related articles for article (PubMed ID: 17924659)
1. Alternative splicing as the basis for specific localization of tNOX, a unique hydroquinone (NADH) oxidase, to the cancer cell surface.
Tang X; Tian Z; Chueh PJ; Chen S; Morré DM; Morré DJ
Biochemistry; 2007 Oct; 46(43):12337-46. PubMed ID: 17924659
[TBL] [Abstract][Full Text] [Related]
2. Antisense experiments demonstrate an exon 4 minus splice variant mRNA as the basis for expression of tNOX, a cancer-specific cell surface protein.
Tang X; Morré DJ; Morré DM
Oncol Res; 2007; 16(12):557-67. PubMed ID: 18351130
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface.
Chueh PJ; Kim C; Cho N; Morré DM; Morré DJ
Biochemistry; 2002 Mar; 41(11):3732-41. PubMed ID: 11888291
[TBL] [Abstract][Full Text] [Related]
4. hnRNP F directs formation of an exon 4 minus variant of tumor-associated NADH oxidase (ENOX2).
Tang X; Kane VD; Morré DM; Morré DJ
Mol Cell Biochem; 2011 Nov; 357(1-2):55-63. PubMed ID: 21625959
[TBL] [Abstract][Full Text] [Related]
5. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate.
Chueh PJ; Wu LY; Morré DM; Morré DJ
Biofactors; 2004; 20(4):235-49. PubMed ID: 15706060
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface.
Yantiri F; Morré DJ
Arch Biochem Biophys; 2001 Jul; 391(2):149-59. PubMed ID: 11437345
[TBL] [Abstract][Full Text] [Related]
7. Cell size increased in tissues from transgenic mice overexpressing a cell surface growth-related and cancer-specific hydroquinone oxidase, tNOX, with protein disulfide-thiol interchange activity.
Yagiz K; Snyder PW; Morré DJ; Morré DM
J Cell Biochem; 2008 Dec; 105(6):1437-42. PubMed ID: 18980249
[TBL] [Abstract][Full Text] [Related]
8. Effect of Ccapsaicin on tNOX (ENOX2) protein expression in stomach cancer cells.
Wang HM; Chueh PJ; Chang SP; Yang CL; Shao KN
Biofactors; 2008; 34(3):209-17. PubMed ID: 19734122
[TBL] [Abstract][Full Text] [Related]
9. Surface NADH oxidase of HeLa cells lacks intrinsic membrane binding motifs.
Morré DJ; Sedlak D; Tang X; Chueh PJ; Geng T; Morré DM
Arch Biochem Biophys; 2001 Aug; 392(2):251-6. PubMed ID: 11488599
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mouse line overexpressing the cancer-specific tNOX protein has an enhanced growth and acquired drug-response phenotype.
Yagiz K; Morré DJ; Morré DM
J Nutr Biochem; 2006 Nov; 17(11):750-9. PubMed ID: 16517149
[TBL] [Abstract][Full Text] [Related]
11. A site-directed mutagenesis analysis of tNOX functional domains.
Chueh PJ; Morré DM; Morré DJ
Biochim Biophys Acta; 2002 Jan; 1594(1):74-83. PubMed ID: 11825610
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated NADH oxidase (tNOX)-NAD+-sirtuin 1 axis contributes to oxaliplatin-induced apoptosis of gastric cancer cells.
Chen HY; Cheng HL; Lee YH; Yuan TM; Chen SW; Lin YY; Chueh PJ
Oncotarget; 2017 Feb; 8(9):15338-15348. PubMed ID: 28122359
[TBL] [Abstract][Full Text] [Related]
13. Update on a tumor-associated NADH oxidase in gastric cancer cell growth.
Cheng HL; Lee YH; Yuan TM; Chen SW; Chueh PJ
World J Gastroenterol; 2016 Mar; 22(10):2900-5. PubMed ID: 26973386
[TBL] [Abstract][Full Text] [Related]
14. RNA interference targeting tNOX attenuates cell migration via a mechanism that involves membrane association of Rac.
Liu SC; Yang JJ; Shao KN; Chueh PJ
Biochem Biophys Res Commun; 2008 Jan; 365(4):672-7. PubMed ID: 18023414
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of serine-504 of tNOX (ENOX2) modulates cell proliferation and migration in cancer cells.
Zeng ZM; Chuang SM; Chang TC; Hong CW; Chou JC; Yang JJ; Chueh PJ
Exp Cell Res; 2012 Aug; 318(14):1759-66. PubMed ID: 22659163
[TBL] [Abstract][Full Text] [Related]
16. Cancer type-specific tNOX isoforms: A putative family of redox protein splice variants with cancer diagnostic and prognostic potential.
Morré DJ; Hostetler B; Weston N; Kim C; Morré DM
Biofactors; 2008; 34(3):201-7. PubMed ID: 19734121
[TBL] [Abstract][Full Text] [Related]
17. tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal anti-inflammatory drugs (NSAIDS).
Morré DJ; Morre DM
Mol Cell Biochem; 2006 Feb; 283(1-2):159-67. PubMed ID: 16444599
[TBL] [Abstract][Full Text] [Related]
18. ECTO-NOX target for the anticancer isoflavene phenoxodiol.
Morré DJ; Chueh PJ; Yagiz K; Balicki A; Kim C; Morré DM
Oncol Res; 2007; 16(7):299-312. PubMed ID: 17518268
[TBL] [Abstract][Full Text] [Related]
19. Cancer isoform of a tumor-associated cell surface NADH oxidase (tNOX) has properties of a prion.
Kelker M; Kim C; Chueh PJ; Guimont R; Morré DM; Morré DJ
Biochemistry; 2001 Jun; 40(25):7351-4. PubMed ID: 11412089
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of tumor-associated NADH oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth.
Wang HM; Chuang SM; Su YC; Li YH; Chueh PJ
Cell Biochem Biophys; 2011 Nov; 61(2):355-66. PubMed ID: 21735133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
